#AACR16 Update: New Hope for Patients with Rare Skin Cancer, Head & Neck Cancer April 20, 2016December 14, 2022 Brian Brewer
ASCO 2016 Update: Immunotherapy’s Impact in Head & Neck Cancers June 16, 2016December 14, 2022 Arthur N. Brodsky, PhD
FDA Approves Pembrolizumab (Keytruda®), a PD-1 Antibody, for Head and Neck Cancer August 8, 2016December 14, 2022 Alexandra Mulvey
Head and Neck Cancer Awareness Month: 2021 Immunotherapy Research Updates April 7, 2021December 14, 2022 CRI Staff